Patrick J Loehrer Sr
Overview
Explore the profile of Patrick J Loehrer Sr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monge C, Eldridge L, Pearlman P, Venkatesh V, Tregear M, Loehrer Sr P, et al.
J Natl Cancer Inst Monogr
. 2025 Feb;
2025(68):35-41.
PMID: 39989041
Patient-centered clinical trials prioritize the patient experience and outcomes that matter most to those affected by cancer. By centering on patient values and experiences, patient-centered outcomes research generates evidence to...
2.
Maniar R, Loehrer Sr P
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254905
Thymic epithelial tumors (TETs), which include thymomas and thymic carcinomas, are a rare, heterogeneous group of malignancies that originate from the thymus gland. As an important organ of immune cell...
3.
4.
Burns M, Secinti E, Johns S, Wu W, Helft P, Turk A, et al.
J Contextual Behav Sci
. 2023 Apr;
27:107-115.
PMID: 37064761
Patients with advanced gastrointestinal cancer often experience high symptom burden, which is associated with heightened distress in both patients and their family caregivers. Few interventions have been tested to jointly...
5.
Maniar R, Loehrer Sr P
Cancer
. 2023 Feb;
129(8):1162-1172.
PMID: 36808725
Thymic epithelial tumors (TETs) are a rare group of malignancies arising from the thymus. Surgery remains the foundation of treatment for patients with early-stage disease. Limited treatment options are available...
6.
Abu Zaid M, Radovich M, Althouse S, Liu H, Spittler A, Solzak J, et al.
Front Oncol
. 2022 Nov;
12:891383.
PMID: 36330484
Purpose: To investigate the efficacy and safety of buparlisib, an oral pan-PI3K inhibitor, in relapsed or refractory thymomas. Methods: This was a single center, single arm, open label phase II...
7.
Swift S, Lopes Abath Neto O, Bagheri M, Saleh A, Loehrer Sr P, Rajan A
JTO Clin Res Rep
. 2021 Sep;
1(3):100039.
PMID: 34589936
No abstract available.
8.
Mosher C, Secinti E, Kroenke K, Helft P, Turk A, Loehrer Sr P, et al.
Pilot Feasibility Stud
. 2021 Apr;
7(1):99.
PMID: 33879253
Background: Fatigue interference with activities, mood, and cognition is one of the most prevalent and bothersome concerns of advanced gastrointestinal (GI) cancer patients. As fatigue interferes with patient functioning, family...
9.
Eberle M, Ashenef A, Gerba H, Loehrer Sr P, Lieberman M
JCO Glob Oncol
. 2020 Mar;
6:407-413.
PMID: 32142404
Purpose: A postmarket evaluation of chemotherapy dosage forms in Ethiopia was conducted to test the accuracy of the chemoPAD, a paper analytical device for drug quality screening. Materials And Methods:...
10.
Hellyer J, Gubens M, Cunanan K, Padda S, Burns M, Spittler A, et al.
Lung Cancer
. 2019 Sep;
137:71-75.
PMID: 31557562
Objectives: There are limited treatment options for patients with thymic malignancies. Here we present data supporting treatment with single agent amrubicin, a third generation anthracycline and topoisomerase II inhibitor. Materials...